Retrieved March 15, 2025, from [ \- Link Opens in New Tab]( National Health Service
Pain management remains essential for rib injury recovery
J Urol 1998
The side effects of BPC-157 are not fully documented due to its investigational status, but current research and anecdotal reports suggest it is generally well-tolerated
Administration Routes in Research Multiple delivery methods have been investigated for component peptides: Subcutaneous injection Most common route for combined formulations in research Intraperitoneal injection Used in systemic studies, University of Zagreb School of Medicine, Zagreb, Croatia Professor Predrag Sikiric has been the primary investigator for BPC-157 research since the 1990s, establishing the foundational research base for one of the key components in GLOW Peptide Blend
However, when the mice were treated with Dihexa, levels of both IL-1-beta and TNF-alpha were found to significantly decrease